Runhui H. Wu

Beijing Key Laboratory Of Key Technologies For Prevention And Treatment Of Emerging And Sudden Infectious Diseases In Children, Key Laboratory Of Major Diseases In Children
Beijing, 100045, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 183 publications

Clinical characteristics of periorbital and orbital cellulitis in children

Clinical characteristics of periorbital and orbital cellulitis in children

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: July 29, 2026

Physiologically Based Pharmacokinetic (PBPK) Modeling of FIX in Pediatric Hemophilia B: Extravascular Distribution and Dosing Optimization.

Physiologically Based Pharmacokinetic (PBPK) Modeling of FIX in Pediatric Hemophilia B: Extravascular Distribution and Dosing Optimization.

Journal: Pharmaceutics

Published: July 13, 2026

Sea-blue histiocytosis and thrombocytopenia successfully treated with an mTORC1 inhibitor: a case report.

Sea-blue histiocytosis and thrombocytopenia successfully treated with an mTORC1 inhibitor: a case report.

Journal: Annals of hematology

Published: April 10, 2026

Long-term efficacy analysis of the individualized prophylaxis regimen in children with moderate or severe haemophilia A

Long-term efficacy analysis of the individualized prophylaxis regimen in children with moderate or severe haemophilia A

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: March 16, 2026

Plasma metabolomics profile alterations in the onset and progression of paediatric immune thrombocytopenia.

Plasma metabolomics profile alterations in the onset and progression of paediatric immune thrombocytopenia.

Journal: British journal of haematology

Published: March 15, 2026

Pseudoexon inclusion induced by three deep intronic variants in hemophilia B and correction achieved through an antisense oligonucleotide-based strategy.

Pseudoexon inclusion induced by three deep intronic variants in hemophilia B and correction achieved through an antisense oligonucleotide-based strategy.

Journal: Thrombosis research

Published: January 29, 2026

Emicizumab prophylaxis vs immune tolerance induction in children with severe hemophilia A and inhibitors: a retrospective comparison of bleeding control, quality of life, and cost.

Emicizumab prophylaxis vs immune tolerance induction in children with severe hemophilia A and inhibitors: a retrospective comparison of bleeding control, quality of life, and cost.

Journal: Research and practice in thrombosis and haemostasis

Published: December 20, 2025

Barriers to dental care and parental attitudes toward oral health in children with haemophilia: a cross-sectional study in China.

Barriers to dental care and parental attitudes toward oral health in children with haemophilia: a cross-sectional study in China.

Journal: European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry

Published: October 20, 2025

Emicizumab prophylaxis in children with hemophilia A with factor VIII inhibitors in China (HAVEN 5).

Emicizumab prophylaxis in children with hemophilia A with factor VIII inhibitors in China (HAVEN 5).

Journal: Chinese medical journal

Published: October 16, 2025

Interpretation of the guidelines for the diagnosis and treatment of children with hemophilia (2025)

Interpretation of the guidelines for the diagnosis and treatment of children with hemophilia (2025)

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: October 14, 2025

Clinical efficacy and safety of Octocog alfa in Chinese patients with hemophilia A: One-year follow-up results from the Antihemophilic Factor Hemophilia A Outcome Database (AHEAD) study

Clinical efficacy and safety of Octocog alfa in Chinese patients with hemophilia A: One-year follow-up results from the Antihemophilic Factor Hemophilia A Outcome Database (AHEAD) study

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: October 14, 2025

Precision strategies for personalized prophylaxis in pediatric hemophilia with coagulation factor and non-factor therapies

Precision strategies for personalized prophylaxis in pediatric hemophilia with coagulation factor and non-factor therapies

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: October 14, 2025

Showing 1-12 of 183

Last Updated: 09/26/2026